Target Cell Limited and Immune Control Models of HIV Infection : A Comparison
暂无分享,去创建一个
R J D B | A S P | R. J. D B | A. P | A. P.
[1] M. Zupancic,et al. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. , 1997, Science.
[2] H. Schuitemaker,et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics , 1995, The Journal of experimental medicine.
[3] Peter A. Abrams,et al. The Fallacies of "Ratio‐Dependent" Predation , 1994 .
[4] C. Rinaldo,et al. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors , 1995, Journal of virology.
[5] M. Mihatsch,et al. THE EFFECT OF CYCLOSPORINE ON THE PROGRESSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION TRANSMITTED BY TRANSPLANTATION–DATA ON FOUR CASES AND REVIEW OF THE LITERATURE , 1993, Transplantation.
[6] M A Savageau,et al. Network regulation of the immune response: alternative control points for suppressor modulation of effector lymphocytes. , 1985, Journal of immunology.
[7] A S Perelson,et al. Modeling HIV infection of CD4+ T-cell subpopulations. , 1994, Journal of theoretical biology.
[8] J. Coffin,et al. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy , 1995, Science.
[9] B. Larder,et al. Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects. , 1992, The Journal of infectious diseases.
[10] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.
[11] J M Andrieu,et al. Effects of cyclosporin on T-cell subsets in human immunodeficiency virus disease. , 1988, Clinical immunology and immunopathology.
[12] Steven M. Wolinsky,et al. Adaptive Evolution of Human Immunodeficiency Virus-Type 1 During the Natural Course of Infection , 1996, Science.
[13] J. Lisziewicz,et al. Long-term suppression of HIV-1 by hydroxyurea and didanosine. , 1997, JAMA.
[14] C. Boucher,et al. Host-parasite dynamics and outgrowth of virus containing a single K70R amino acid change in reverse transcriptase are responsible for the loss of human immunodeficiency virus type 1 RNA load suppression by zidovudine. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[15] Niels Schaft,et al. T cell telomere length in HIV-1 infection: No evidence for increased CD4+ T cell turnover☆ , 1997 .
[16] M P Dempsey,et al. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. , 1991, Science.
[17] Lymphocyte dynamics, apoptosis and HIV infection. , 1996, Trends in microbiology.
[18] David Gray,et al. Immunological Memory and Protective Immunity: Understanding Their Relation , 1996, Science.
[19] W. O'brien,et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. , 1995, Blood.
[20] Andrew H. Liu,et al. HIV INFECTION IS ACTIVE AND PROGRESSIVE IN LYMPHOID TISSUE DURING THE CLINICALLY LATENT STAGE OF DISEASE , 1995, Pediatrics.
[21] J. Levy,et al. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. , 1996, Immunology today.
[22] F. Biron,et al. 1–year follow-up of the use of hydroxycarbamide and didanosine in HIV infection , 1996, The Lancet.
[23] M A Nowak,et al. Human immunodeficiency virus drug therapy and virus load , 1997, Journal of virology.
[24] M A Nowak,et al. Mathematical biology of HIV infections: antigenic variation and diversity threshold. , 1991, Mathematical biosciences.
[25] D. Richman,et al. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. , 1989, Science.
[26] T. Elbeik,et al. Activation of virus replication after vaccination of HIV-1-infected individuals , 1995, The Journal of experimental medicine.
[27] S. Swindells,et al. Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine. , 1996, The Journal of infectious diseases.
[28] H. Resit Akçakaya,et al. Consequences of Ratio‐Dependent Predation for Steady‐State Properties of Ecosystems , 1992 .
[29] Hydroxyurea treatment in HIV-infected patients. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[30] G. Pantaleo. How immune-based interventions can change HIV therapy , 1997, Nature Medicine.
[31] M A Savageau,et al. Network regulation of the immune response: modulation of suppressor lymphocytes by alternative signals including contrasuppression. , 1985, Journal of immunology.
[32] R. Ellison,et al. Hepatitis B vaccination and plasma HIV-1 RNA. , 1996, The New England journal of medicine.
[33] R. J. de Boer,et al. A Formal Derivation of the “Beddington” Functional Response , 1997 .
[34] C. Harley,et al. Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. , 1996, AIDS.
[35] J. Metcalf,et al. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study. , 1995, The New England journal of medicine.
[36] D Schenzle,et al. A model for AIDS pathogenesis. , 1994, Statistics in medicine.
[37] F. Miedema,et al. Programmed death of T cells in HIV-1 infection. , 1992, Science.
[38] M. Giacca,et al. Treatment of human immunodeficiency virus infection with hydroxyurea: virologic and clinical evaluation. , 1996, The Journal of infectious diseases.
[39] R. D. de Boer,et al. Diversity and virulence thresholds in AIDS. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[40] L M Wahl,et al. Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[41] A S Perelson,et al. T cell repertoires and competitive exclusion. , 1994, Journal of theoretical biology.
[42] Alan S. Perelson,et al. Decay characteristics of HIV-1-infected compartments during combination therapy , 1997, Nature.
[43] J. Beddington,et al. Mutual Interference Between Parasites or Predators and its Effect on Searching Efficiency , 1975 .
[44] M A Nowak,et al. Models of interactions between HIV and other pathogens. , 1992, Journal of theoretical biology.
[45] F. de Wolf,et al. Biphasic rate of CD4+ cell count decline during progression to AIDS correlates with HIV‐1 phenotype , 1992, AIDS.
[46] M. Clerici,et al. Protective immunity against HIV infection: has nature done the experiment for us? , 1996, Immunology today.
[47] M A Nowak,et al. Competition between zidovudine‐sensitive and zidovudine‐resistant strains of HIV , 1992, AIDS.
[48] C. Benson,et al. Viral Dynamics in Human Immunodeficiency Virus Type 1 Infection , 1995 .
[49] M A Nowak,et al. Antigenic diversity thresholds and the development of AIDS. , 1991, Science.
[50] Alan S. Perelson,et al. Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue , 1996, Science.
[51] C H Fox,et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. , 1996, The New England journal of medicine.
[52] R. Siliciano,et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.
[53] M. Cloyd,et al. How does HIV cause AIDS? The homing theory. , 2000, Molecular medicine today.
[54] M. Nowak,et al. Population Dynamics of Immune Responses to Persistent Viruses , 1996, Science.
[55] W. Lu,et al. Sustained increases in CD4 cell counts in asymptomatic human immunodeficiency virus type 1-seropositive patients treated with prednisolone for 1 year. , 1995, The Journal of infectious diseases.
[56] A. Hastings,et al. Chaos in a Three-Species Food Chain , 1991 .
[57] A. Perelson,et al. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.
[58] C. Boucher,et al. Clinical data sets of human immunodeficiency virus type 1 reverse transcriptase-resistant mutants explained by a mathematical model , 1997, Journal of virology.
[59] John W. Mellors,et al. Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.
[60] D. Ho,et al. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression , 1994, Journal of virology.
[61] A. Fauci,et al. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. , 1993, Science.
[62] S. Staszewski,et al. Turnover of circulating virion RNA and of cell-associated viral DNA reflects active viral replication in human immunodeficiency virus type 1-infected individuals , 1995, Journal of virology.
[63] Lange,et al. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates , 1989, Journal of virology.
[64] T. Kirkwood,et al. A model of human immunodeficiency virus infection in T helper cell clones. , 1990, Journal of theoretical biology.
[65] L. Corey,et al. Reducing T cell activation as a therapy for human immunodeficiency virus infection. , 1995, The Journal of infectious diseases.
[66] C. Boucher,et al. Anti-CD4 therapy for AIDS suggested by mathematical models , 1996, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[67] Andrew N. Phillips,et al. Reduction of HIV Concentration During Acute Infection: Independence from a Specific Immune Response , 1996, Science.
[68] M A Nowak,et al. HIV results in the frame. Results confirmed. , 1995, Nature.
[69] Xiping Wei,et al. Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.
[70] D. Weissman,et al. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. , 1996, Journal of immunology.
[71] Martin A. Nowak,et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS , 1997, Nature Medicine.
[72] S. Frost,et al. Quasispecies dynamics and the emergence of drug resistance during zidovudine therapy of HIV infection , 1994, AIDS.
[73] B L Levine,et al. Human naive and memory T lymphocytes differ in telomeric length and replicative potential. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[74] S Galpin,et al. HIV results in the frame. Cyclosporin A. , 1995, Nature.
[75] A S Perelson,et al. Towards a general function describing T cell proliferation. , 1995, Journal of theoretical biology.